Solu-medrol and Weakness - a phase IV clinical study of FDA data

Summary:

We study 36,773 people who have side effects when taking Solu-medrol. Weakness is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Benadryl and have Pain.

The phase IV clinical study analyzes which people take Solu-medrol and have Weakness. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2023

36,773 people reported to have side effects when taking Solu-medrol.
Among them, 2,282 people (6.21%) have Weakness.

What is Solu-medrol?

Solu-medrol has active ingredients of methylprednisolone sodium succinate. It is used in multiple sclerosis. Currently, eHealthMe is studying from 36,918 Solu-medrol users.

What is Weakness?

Weakness is found to be associated with 5,187 drugs and 6,387 conditions by eHealthMe. Currently, we are studying 555,945 people who have Weakness.

Number of Solu-medrol and Weakness reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Solu-medrol and have Weakness?

Check whether Weakness is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Solu-medrol side effects by duration, gender and age:

Solu-medrol side effects (36,918 reports)

Weakness treatments and more:

Weakness (555,945 reports)

Common drugs associated with Weakness:

All the drugs that are associated with Weakness:

Weakness (5,187 drugs)

Common conditions associated with Weakness:

Multiple sclerosis: 46,186 reports
Rheumatoid arthritis: 25,514 reports
High blood pressure: 24,528 reports
High blood cholesterol: 18,449 reports
Pain: 16,157 reports

All the conditions that are associated with Weakness:

Weakness (6,387 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on methylprednisolone sodium succinate (the active ingredients of Solu-medrol) and Solu-medrol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.